10-Q: Aeluma Inc. Reports Increased Revenue but Widens Net Loss in Q2 2025
Quarterly Report
Aeluma Inc. reports a significant increase in revenue driven by government contracts, but also a widened net loss for the quarter ended December 31, 2024.
Summary
- Aeluma Inc. reported its financial results for the second quarter of fiscal year 2025, ended December 31, 2024.
- Revenue increased significantly to $2,093,254, compared to $295,392 for the same period in 2023, primarily driven by government contracts.
- The company's net loss widened to $3,624,443, compared to a net loss of $2,610,829 for the same period in 2023.
- Operating expenses decreased by 16.2% to $2,435,036, due to decreases in consulting and professional expenses and less purchases for R&D activities.
- The company issued convertible promissory notes for $3,145,000 between August 5, 2024, and August 27, 2024.
- Aeluma won an $11.717 million DARPA contract in September 2024 for nano-scale semiconductors.
- The company acknowledges it needs additional funding to continue operations and is exploring options including debt and equity financing.
- Aeluma's management has concluded that its disclosure controls and procedures were not effective as of December 31, 2024, due to insufficient staffing resources in the finance department.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While revenue increased significantly, the widening net loss and concerns about financial sustainability offset the positive aspects. The DARPA contract is a positive sign, but the company's future depends on securing additional funding and achieving profitability.
Positives
- Revenue increased significantly due to government contracts, indicating growing market traction.
- The company secured a substantial DARPA contract, validating its technology and potential.
- Operating expenses decreased, suggesting improved cost management.
- The company raised $3,145,000 through convertible notes, providing additional capital.
Negatives
- The net loss increased, indicating ongoing challenges with profitability.
- The company's accumulated deficit is substantial, raising concerns about long-term financial sustainability.
- Disclosure controls and procedures were deemed ineffective, highlighting internal control weaknesses.
- The company acknowledges the need for additional funding, indicating potential financial strain.
Risks
- The company's ability to continue as a going concern is dependent on raising additional capital and achieving sustainable revenues.
- The company's disclosure controls and procedures are not effective, which could lead to inaccurate financial reporting.
- The convertible notes could dilute existing shareholders if converted to common stock.
- The company faces risks inherent in growing an enterprise, including limited capital resources and possible rejection of its products in development.
Future Outlook
The company expects to continue developing its technology, mature its manufacturing processes, and expand its business development and marketing efforts. Aeluma will continue to perform on various customer and government contracts, engage with manufacturing partners, and continue efforts toward volume production and commercialization. The company anticipates needing additional funding to support its operations.
Management Comments
- Management anticipates that significant additional expenditures will be necessary to develop and expand our business before significant positive operating cash flows can be achieved.
- Our ability to continue as a going concern is dependent upon our ability to raise additional capital and to ultimately achieve sustainable revenues and profitable operations.
Industry Context
Aeluma operates in the semiconductor industry, which is experiencing increasing demand for high-performance semiconductors in consumer markets. The company's technology aims to provide scalable and cost-effective solutions for various applications, including mobile, automotive, AI, and defense. The DARPA contract highlights the growing interest in heterogeneous integration technology for advanced semiconductors.
Comparison to Industry Standards
- Comparing Aeluma's performance to industry giants like Intel or TSMC is not directly applicable due to its early stage and focus on specialized optoelectronic devices.
- However, the DARPA contract win positions Aeluma alongside other innovative semiconductor companies such as Teledyne Scientific Company and research institutions like the University of California Santa Barbara.
- Aeluma's revenue growth, while significant, needs to be sustained and translated into profitability to align with industry benchmarks for long-term success.
- The company's focus on heterogeneous integration aligns with the industry trend towards advanced packaging and interconnect technologies, as seen in companies like Amkor Technology and ASE Technology.
Stakeholder Impact
- Shareholders face potential dilution from convertible notes and future equity offerings.
- Employees' job security depends on the company's ability to secure funding and achieve profitability.
- Customers benefit from the company's innovative technology and potential for cost-effective solutions.
- Suppliers and creditors face risks associated with the company's financial instability.
Next Steps
- Continue to develop technology and mature manufacturing processes.
- Expand business development and marketing efforts.
- Perform on customer and government contracts.
- Engage with manufacturing partners.
- Pursue volume production and commercialization.
- Secure additional funding through debt or equity financing.
Key Dates
| Date | Description |
|---|---|
| October 27, 2020 | Company issued shares of common stock to Jonathan Klamkin |
| April 1, 2021 | Company commenced a 5-year operating lease for a facility in Santa Barbara, California |
| June 22, 2021 | Merger of Aeluma Operating Co. with and into Biond Photonics, Inc. |
| July 1, 2023 | Company remeasured the ROU asset and lease liability |
| August 5, 2024 | Start date for issuance of convertible promissory notes |
| August 27, 2024 | End date for issuance of convertible promissory notes |
| September 6, 2024 | Company won $11.717 million DARPA contract |
| December 31, 2024 | End of the quarterly period |
| February 7, 2025 | Date shares of common stock outstanding was reported |
| February 11, 2025 | Date of report |
| June 2026 | Maturity date of the convertible notes |
Keywords
Aeluma, semiconductors, financial results, revenue, net loss, DARPA contract, convertible notes, government contracts, optoelectronic devices, heterogeneous integration
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.